§ 27-19-2. Organization as charitable corporation — Insurance laws inapplicable.
§ 27-19-2.1. Investments and holdings in certain corporations authorized.
§ 27-19-4. Certificate of public convenience and advantage.
§ 27-19-5. Contracts with subscribers, hospitals, and other eligible entities.
§ 27-19-5.1. Cancellation of coverage by employers.
§ 27-19-5.2. Patient responsibility — Administrative requirements.
§ 27-19-5.3. Additional powers.
§ 27-19-6. Rates charged subscribers.
§ 27-19-7. Rates charged by hospitals.
§ 27-19-7.1. Uniform explanation of benefits and coverage.
§ 27-19-7.2. Filing of policy forms.
§ 27-19-8. Annual and quarterly statements.
§ 27-19-9. Examination of affairs of corporations.
§ 27-19-10. Commission plans for solicitors or insurance producers.
§ 27-19-11. Investment standards.
§ 27-19-12. Corporations deemed public charitable institutions.
§ 27-19-13. Services rendered in certain institutions.
§ 27-19-17. Additional benefits.
§ 27-19-18. Coverage for adoptive children.
§ 27-19-19. Changing coverage.
§ 27-19-21. Mammograms — Quality assurance standards.
§ 27-19-22. Pap smears — Quality assurance standards.
§ 27-19-23. Coverage for infertility.
§ 27-19-23.1. Insurance coverage for postpartum hospital stays.
§ 27-19-24. Nonprofit hospital service corporations assessment.
§ 27-19-25. Discontinuance of coverage — Chronic disabilities.
§ 27-19-26.1. Medication synchronization.
§ 27-19-28. Rehabilitation, liquidation, or conservation.
§ 27-19-29. Holding company systems.
§ 27-19-29.1. No derogation of attorney general.
§ 27-19-30.1. Health insurance rates.
§ 27-19-31. Certified counselors in mental health and therapists in marriage and family practice.
§ 27-19-34. Mastectomy treatment.
§ 27-19-34.1. Insurance coverage for mastectomy hospital stays.
§ 27-19-35. Diabetes treatment.
§ 27-19-36. Primary and preventive obstetric and gynecological care.
§ 27-19-36.1. Hysterectomy or myomectomy treatment.
§ 27-19-37. Whistleblowers protection.
§ 27-19-38. Penalties and remedies.
§ 27-19-39. Additional relief and damages — Reinstatement.
§ 27-19-40. Third-party reimbursement for services of certain healthcare workers.
§ 27-19-40.1. Third-party reimbursement for services of registered nurse first assistants.
§ 27-19-41. Human leukocyte antigen testing.
§ 27-19-42.1. Specialty drugs. [Effective January 1, 2025.]
§ 27-19-43. Restricted annual rate payments prohibited.
§ 27-19-44.1. Genetic information.
§ 27-19-46. Magnetic resonance imaging — Quality assurance standards.
§ 27-19-47. Acupuncture services.
§ 27-19-48. FDA approved prescription contraceptive drugs and devices.
§ 27-19-50. Eligibility for children’s benefits.
§ 27-19-52. Prompt processing of claims.
§ 27-19-53. Mandatory coverage for certain lyme disease treatments.
§ 27-19-54. Dental insurance assignment of benefits.
§ 27-19-55. Coverage for early intervention services.
§ 27-19-56. Post-payment audits.
§ 27-19-57. Tobacco cessation programs.
§ 27-19-58. Reimbursement for orthotics and prosthetic services.
§ 27-19-59. Mandatory coverage for scalp hair prosthesis.
§ 27-19-60. Licensed ambulance service.
§ 27-19-61. Enteral nutrition products.
§ 27-19-62. Prohibition on rescission of coverage.
§ 27-19-63. Prohibition on annual and lifetime limits.
§ 27-19-64. Coverage for individuals participating in approved clinical trials.
§ 27-19-65. Medical loss ratio reporting and rebates.
§ 27-19-66. Emergency services.
§ 27-19-67. Internal and external appeal of adverse benefit determinations.
§ 27-19-68. Prohibition on preexisting condition exclusions.
§ 27-19-69. Primary care provider designation requirement.
§ 27-19-70. Discretionary clauses.
§ 27-19-71. Orally administered anticancer medication — Cost-sharing requirement.
§ 27-19-72. Consumer notification.
§ 27-19-73. Opioid antagonists.
§ 27-19-74. Healthcare provider credentialing.
§ 27-19-75. Unfair discrimination prohibited.
§ 27-19-76. Health insurance contracts — Full year coverage for contraception.
§ 27-19-77. Prohibition on discrimination in organ transplants.
§ 27-19-78. Health insurance contracts — Copayments exemption for COVID-19 vaccinations.
§ 27-19-81. Coverage for biomarker testing.
§ 27-19-84. Expedited prior authorization. [Effective January 1, 2024.]
§ 27-19-85. Dispensing and administration of HIV PrEP or PEP drugs. [Effective January 1, 2024.]